HMA is pleased to be working with the NHS on an exciting research project to bring a new app to aid clinicians when prescribing blood components at a patient’s bedside.
HMA won the tender for the work after being approached by NHS Blood and Transplant to propose a solution for the design and development of the app.
Once complete, the app will be used to assess behaviour change in prescribing blood transfusions with the aim to make them safer and encourage the use of evidence based practice.
To deliver the solution HMA is working with a diverse group of medical professionals including junior doctors, consultant haematologists, transfusion practitioners, a quality manager and the NHS Blood and Transplant Technical Lead for the project.
Aman Dhesi, Patient Blood Management – Regional Lead, at NHS Blood and Transplant said: “It is great we are working with HMA on this project to ultimately help improve the safe and appropriate treatment for patients who may need a blood transfusion.”
“Patient Blood Management (PBM) reduces the inappropriate use of blood and blood components to improve patient outcomes.”
The application will be cross platform with the first rollout to be available for IOS and Android devices and will comply with current medical device regulation.
Upon completion of the development cycle, the application will be evaluated and trialled at two NHS hospitals.
This important win is another step forward for HMA in working with the healthcare industry having a previous track record of delivering several award winning mobile healthcare apps.